RxDoctor Payments Data

Kiera Quinn, PA

Physician Assistant · Raleigh, NCNPI 1144830977

Payments from drug & device makers

$1,194in general payments, 2019–2025

Across 66 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$280
  • Novo Nordisk$230
  • AbbVie$100
  • AstraZeneca$81
  • Idorsia Pharmaceuticals US Inc$60
  • Boehringer Ingelheim$59
  • plus $384 from 17 others

What the payments were for

  • Food & beverage$1,194100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,194 in reported general payments places this provider in the 70th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$61,011
Medicare patients
157
Services billed
3,533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide14$25,878
WegovySemaglutide13$24,816
EliquisApixaban26$20,809
XareltoRivaroxaban16$14,752
JardianceEmpagliflozin13$13,841
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$10,061
PaxlovidNirmatrelvir/Ritonavir12$1,429
Atorvastatin Calcium83$1,425
Sertraline Hcl20$1,135
SynthroidLevothyroxine Sodium17$1,039
Rosuvastatin Calcium63$968
Losartan Potassium79$938
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$746
Levothyroxine Sodium50$608
Simvastatin52$549

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$280$25,87814 claims
Novo NordiskWegovy$230$24,81613 claims
PfizerEliquis, Paxlovid$18$22,23938 claims
Boehringer IngelheimJardiance$59$13,84113 claims
AbbVieSynthroid$100$1,03917 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →